July 1, 2026 · Form 4 insider transaction
Spencer John bought 55,900 shares of Oragenics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 6 days after the transaction.
Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended. One fifth of the options vest on the grant date and the remainder of the options subsequently vest in equal annual installments over the first, second, third and fourth anniversary of the grant date upon the continued performance of services by the Reporting Person to the Company through the vesting dates. The option exercise price is the Company's closing price on the date of grant.